Related Experiment Video
Updated: May 14, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Major depression and PTSD in pregnant smokers enrolled in nicotine gum treatment trial
Ellen Dornelas1, Cheryl Oncken, John Greene
1Department of Medicine, University of Connecticut School of Medicine, Farmington, Connecticut, USA. edornel@harthosp.org
Background And Objectives:
Pregnant women face considerable barriers to smoking cessation. The purpose of this study was to determine the prevalence of major depressive disorder (MDD) and post-traumatic stress disorder (PTSD) and response to smoking cessation treatment in pregnant smokers participating in a randomized, placebo-controlled trial of nicotine gum.
Methods:
Participants were 194 low-income, ethnically diverse pregnant smokers.
Results:
Utilizing a structured interview, 45% and 18% of the subjects met criteria for a lifetime diagnosis of MDD and PTSD, respectively. There was no difference in response to treatment, based on the presence of either of these psychiatric disorders.
Conclusions:
Cumulatively, these findings provide evidence of the high degree of unmet mental health needs in pregnant smokers.
Scientific Significance:
Pregnant women with a history of MDD and PTSD appear to be as likely to benefit from smoking cessation treatment as those without such a history.
More Related Videos
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Stress Prevention and Stress Management Techniques IV